Share price of Morepen Laboratories surged over 8 percent intraday on April 21 after the company received license to manufacture Hydroxychloroquine (HCQ) from State Drug Controller, (HP) last week for its Baddi plant in Himachal Pradesh.
Morepen Laboratories has launched a wide range of essential products being required to combat the growing menace of COVID-19 and to prevent further spread of this disease in the country. These include non-contact Infrared thermometers, alcohol-based hand sanitizers, hand wash, hand rubs and face masks, the company said in a filing to the exchanges.
The Company has also received license to manufacture Hydroxychloroquine (HCQ) from State Drug Controller, (HP) last week for its Baddi plant in Himachal Pradesh and is working to commercialize the production of HCQ in both API as well as tablets form, it added.
"The contagion is spreading fast in every nook and corner of our country. As a result, we are working round the clock to maintain regular supply of all essential items and medical supplies required in the process even during these difficult times. We stand firmly with the Govt. of India and customers with all the vigor and commitment to help fight COVID-19,” said Sushil Suri, Chairman and Managing Director of Morepen Laboratories.
The stock price surged over 73 percent in the last 1 month and was quoting at Rs 15.59, up Rs 0.98, or 6.71 percent at 09:33 hrs. It has touched an intraday high of Rs 15.89 and an intraday low of Rs 15.35.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
